Clinical trials
Terminated Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
265 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 5 |
| 2004 | 5 |
| 2005 | 8 |
| 2006 | 14 |
| 2007 | 18 |
| 2008 | 17 |
| 2009 | 21 |
| 2010 | 20 |
| 2011 | 20 |
| 2012 | 18 |
| 2013 | 10 |
| 2014 | 12 |
| 2015 | 18 |
| 2016 | 14 |
| 2017 | 10 |
| 2018 | 14 |
| 2019 | 12 |
| 2020 | 5 |
| 2021 | 6 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 265 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seung-Jung Park | 11 |
| Abbott Medical Devices | 6 |
| Ottawa Heart Institute Research Corporation | 6 |
| Yonsei University | 5 |
| Cordis US Corp. | 4 |
| GE Healthcare | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| CHEOL WHAN LEE, M.D., Ph.D | 3 |
| Corewell Health East | 3 |
| Duk-Woo Park, MD | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 265 |
| Myocardial Infarction | 21 |
| Acute Coronary Syndrome | 19 |
| Myocardial Ischemia | 18 |
| Cardiovascular Diseases | 16 |
| Heart Diseases | 16 |
| Atherosclerosis | 15 |
| Chest Pain | 12 |
| Coronary Disease | 12 |
| Angina Pectoris | 11 |
Trials
Showing 26 to 50 of 265. Each trial links to its page on Pharma Observatory.
165 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.